Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
NOD-like receptor signaling pathway	24/181	2.296448776462978E-10	5.121080771512441E-8	0	0	5.552700708913599	123.23934375690504	RNF31;GBP5;IFNB1;STAT1;STAT2;CARD9;CYBB;NOD2;ANTXR1;IL6;AIM2;CASP5;OAS1;IFI16;OAS2;OAS3;CCL2;GBP2;TLR4;GBP1;MYD88;IRF9;GBP4;GBP3
Influenza A	21/172	1.3759366090695668E-8	1.534169319112567E-6	0	0	5.024853039660689	90.95760881497198	RSAD2;DDX58;IFNB1;STAT1;MX2;STAT2;MX1;EIF2AK2;IFIH1;CXCL10;IL6;OAS1;OAS2;OAS3;TNFSF10;CCL2;TLR7;JAK2;TLR4;MYD88;IRF9
Cell cycle	17/124	5.953955732213213E-8	4.425773760945155E-6	0	0	5.710766772052948	95.00788477141282	PLK1;BUB1B;CDC7;TTK;CDC25C;PKMYT1;CDC25A;CDC20;CCNA2;CCNB1;ORC6;CDC45;CCNE2;ORC1;CDK1;E2F1;BUB1
Viral protein interaction with cytokine and cytokine receptor	15/100	1.0651016234308071E-7	5.93794155062675E-6	0	0	6.326797385620915	101.57689295005386	CX3CR1;CCL13;CXCL9;IL10RA;TNFRSF10C;CXCL10;CXCL11;IL6;IL18RAP;CCL8;CCL7;TNFSF10;CCL2;CCL1;CCR2
Coronavirus disease	23/232	1.4406878952824648E-7	6.4254680129597935E-6	0	0	3.9790984638630067	62.68263841040465	IFNB1;STAT1;DDX58;STAT2;MX2;MX1;EIF2AK2;CYBB;ISG15;IFIH1;C4A;CXCL10;IL6;OAS1;OAS2;OAS3;TLR8;CCL2;TLR7;TLR4;CFB;MYD88;IRF9
Measles	17/139	3.2151543400496106E-7	1.1949656963851052E-5	0	0	5.004738253397526	74.8219393729979	DDX58;IFNB1;STAT1;MX2;STAT2;MX1;EIF2AK2;IFIH1;IL6;CCNE2;OAS1;OAS2;OAS3;TLR7;TLR4;MYD88;IRF9
Homologous recombination	9/41	1.4507683604944878E-6	4.6217334912895826E-5	0	0	9.999828296703297	134.4318641018605	BLM;BRIP1;RAD51;EME1;XRCC2;RAD54L;BRCA1;BRCA2;RAD54B
Toll-like receptor signaling pathway	13/104	6.120593303009583E-6	1.706115383213921E-4	0	0	5.101212440695836	61.23419671622479	CD86;CXCL9;IFNB1;STAT1;CD80;CXCL10;CXCL11;IL6;TLR8;TLR7;CD14;TLR4;MYD88
Hepatitis C	16/157	7.981928971648477E-6	1.977744622975123E-4	0	0	4.064053474387821	47.705202648603354	RSAD2;DDX58;IFNB1;STAT1;MX2;STAT2;MX1;EIF2AK2;IFIT1;CXCL10;OAS1;OAS2;OAS3;CLDN7;E2F1;IRF9
Cytokine-cytokine receptor interaction	23/295	9.130185300874919E-6	2.036031322095107E-4	0	0	3.0474554953560373	35.362443691653624	CX3CR1;IL15RA;CCL13;CXCL9;CD70;IFNB1;IL10RA;TNFRSF9;TNFRSF10C;IL27;TNFSF13B;CXCL10;CXCL11;IL6;IL18RAP;CCL8;CCL7;TNFSF10;IL21R;CCL2;CCL1;IL7R;CCR2
Fanconi anemia pathway	9/54	1.598022922805869E-5	3.239628288960989E-4	0	0	7.106227106227106	78.48229688537121	FANCI;RMI2;BLM;BRIP1;RAD51;EME1;FANCM;BRCA1;BRCA2
Epstein-Barr virus infection	16/202	1.718340460893448E-4	0.0030068375651667078	0	0	3.0736329722504836	26.645267052218273	IFNB1;STAT1;DDX58;STAT2;EIF2AK2;ISG15;CCNA2;CXCL10;IL6;CCNE2;OAS1;OAS2;OAS3;E2F1;MYD88;IRF9
Hepatitis B	14/162	1.752864948303462E-4	0.0030068375651667078	0	0	3.374107009042314	29.18295117340238	DDX58;IFNB1;STAT1;STAT2;IFIH1;CCNA2;IL6;CCNE2;E2F1;STAT4;BIRC5;JAK2;TLR4;MYD88
Oocyte meiosis	12/129	2.5440722041261145E-4	0.0040523435822865965	0	0	3.650753175615054	30.21573007240516	CDC20;SGO1;CCNB1;CCNE2;PLK1;CDK1;CALML4;CDC25C;PKMYT1;ADCY7;BUB1;REC8
Chemokine signaling pathway	15/192	3.1518843071193497E-4	0.0046858013365841	0	0	3.0238543628374135	24.379341697163238	CX3CR1;CCL13;CXCL9;STAT1;STAT2;ADCY7;CXCL10;GRK3;CXCL11;CCL8;CCL7;CCL2;CCL1;JAK2;CCR2
Tuberculosis	14/180	5.168291645597592E-4	0.007203306481051643	0	0	3.0054339353718014	22.74451744853446	IFNB1;STAT1;IL10RA;CARD9;CALML4;NOD2;IL6;FCGR3A;CLEC7A;CD14;JAK2;TLR4;FCGR2C;MYD88
Necroptosis	12/159	0.0016412263829070647	0.021529028434604438	0	0	2.9011914157928365	18.60334314344953	RNF31;IFNB1;STAT1;JMJD7-PLA2G4B;STAT2;TNFSF10;STAT4;CYBB;EIF2AK2;JAK2;TLR4;IRF9
Progesterone-mediated oocyte maturation	9/100	0.0018549843784012165	0.022981195354637295	0	0	3.505736022219539	22.050655400795286	CCNA2;CCNB1;PLK1;CDK1;CDC25C;PKMYT1;ADCY7;BUB1;CDC25A
Inflammatory bowel disease	7/65	0.002112222423001718	0.02479082106996753	0	0	4.269726906619683	26.30158010312242	IL6;IL18RAP;STAT1;IL21R;STAT4;NOD2;TLR4
African trypanosomiasis	5/37	0.0033816830241945365	0.03770576571976908	0	0	5.515056818181818	31.37726365163834	IL6;VCAM1;IDO2;MYD88;IDO1
Leishmaniasis	7/77	0.005493825530008022	0.057157428768032995	0	0	3.5355839416058394	18.39964004293756	FCGR3A;STAT1;CYBB;JAK2;TLR4;FCGR2C;MYD88
JAK-STAT signaling pathway	11/162	0.00563884947487321	0.057157428768032995	0	0	2.5836823139851965	13.378501387323073	IL15RA;IL6;IFNB1;STAT1;IL10RA;STAT2;IL21R;STAT4;IL7R;JAK2;IRF9
C-type lectin receptor signaling pathway	8/104	0.008403973077401665	0.08148199983741614	0	0	2.9477452772699575	14.087424129432927	IL6;CLEC4D;CLEC7A;STAT1;STAT2;CARD9;CALML4;IRF9
Intestinal immune network for IgA production	5/48	0.010361233300383473	0.09627312608272975	0	0	4.101902748414377	18.74439937866395	CD86;IL15RA;IL6;CD80;TNFSF13B
Cellular senescence	10/156	0.011886232261985114	0.10512922470144584	0	0	2.425411587281639	10.750332474929161	CCNA2;CCNB1;IL6;CCNE2;CDK1;E2F1;MYBL2;CALML4;FOXM1;CDC25A
Malaria	5/50	0.012257219023486959	0.10512922470144584	0	0	3.919191919191919	17.25087273252396	IL6;VCAM1;CCL2;TLR4;MYD88
RIG-I-like receptor signaling pathway	6/70	0.013018292653261989	0.10752145413620087	0	0	3.3095969945355193	14.368283675291647	IFIH1;CXCL10;DDX58;IFNB1;DHX58;ISG15
Staphylococcus aureus infection	7/95	0.016547871025676793	0.13179197281164018	0	0	2.8097835102853352	11.524320954373861	C4A;FCGR3A;CFH;FPR3;FPR2;FCGR2C;CFB
Lipid and atherosclerosis	12/215	0.0172606538891638	0.13272847645805266	0	0	2.0947663500530713	8.50333889993211	CYP2J2;IL6;VCAM1;IFNB1;TNFSF10;CYBB;CCL2;CALML4;CD14;JAK2;TLR4;MYD88
Pertussis	6/76	0.018914362076604584	0.13897196860382222	0	0	3.0249804839968775	12.002619649205617	C4A;IL6;CALML4;CD14;TLR4;MYD88
Pyrimidine metabolism	5/56	0.019318973213984254	0.13897196860382222	0	0	3.457040998217469	13.643791692222084	RRM2;CMPK2;TK1;TYMS;TYMP
NF-kappa B signaling pathway	7/104	0.025796700199139343	0.1797707545127523	0	0	2.547896756716081	9.318954540358405	CCL13;VCAM1;DDX58;CD14;TLR4;MYD88;TNFSF13B
Cytosolic DNA-sensing pathway	5/63	0.030416072260428504	0.20553891254774415	0	0	3.03871473354232	10.6135745589344	CXCL10;IL6;AIM2;DDX58;IFNB1
Human immunodeficiency virus 1 infection	11/212	0.03497970062052556	0.22942568348168232	0	0	1.9359452736318408	6.4912000476620975	CCNB1;AP1G2;IFNB1;CDK1;CALML4;CDC25C;SAMHD1;TLR4;APOBEC3A;MYD88;APOBEC3B
PD-L1 expression and PD-1 checkpoint pathway in cancer	6/89	0.03738071145029433	0.23816853295473242	0	0	2.549476594904207	8.379110909347474	BATF2;CD274;STAT1;JAK2;TLR4;MYD88
Neutrophil extracellular trap formation	10/189	0.03855407701456926	0.23882108817358183	0	0	1.9748859617651582	6.429623241696987	FCGR3A;SIGLEC9;CLEC7A;AQP9;CYBB;TLR8;FPR3;TLR7;FPR2;TLR4
Kaposi sarcoma-associated herpesvirus infection	10/193	0.04342203912909838	0.26170580339970106	0	0	1.9313179926806037	6.058135398604779	CD86;IL6;IFNB1;STAT1;STAT2;E2F1;EIF2AK2;CALML4;JAK2;IRF9
Rheumatoid arthritis	6/93	0.044783996758653334	0.2628113493994656	0	0	2.4317567991960303	7.552804187550421	CD86;IL6;CD80;CCL2;TLR4;TNFSF13B
IL-17 signaling pathway	6/94	0.0467676266976437	0.26741489111729605	0	0	2.403999006458023	7.362400939782153	CXCL10;IL6;CCL7;CCL2;S100A9;S100A8
p53 signaling pathway	5/73	0.052104715487730505	0.2864352215001221	0	0	2.590508021390374	7.65365549823372	CCNB1;RRM2;CCNE2;CDK1;GTSE1
Ovarian steroidogenesis	4/51	0.052662977943968625	0.2864352215001221	0	0	2.9961771633779977	8.820273899134714	CYP2J2;JMJD7-PLA2G4B;ALOX5;ADCY7
Cell adhesion molecules	8/148	0.05446937740565868	0.28920645622528296	0	0	2.0167145468790806	5.868874516016072	CD86;CD274;VCAN;VCAM1;CD80;CLDN7;ITGB8;SIGLEC1
AGE-RAGE signaling pathway in diabetic complications	6/100	0.05980254186908831	0.3101387636466673	0	0	2.2498546680618534	6.337181646199063	IL6;VCAM1;STAT1;CYBB;CCL2;JAK2
Osteoclast differentiation	7/127	0.0638302170180778	0.32350314534162156	0	0	2.057101581508516	5.660173793034195	FCGR3A;IFNB1;STAT1;STAT2;LILRB2;FCGR2C;IRF9
Legionellosis	4/57	0.07331898301402004	0.36333629360281045	0	0	2.656165462452488	6.9403896326545835	IL6;CD14;TLR4;MYD88
Human papillomavirus infection	14/331	0.07892298630062514	0.376967923629011	0	0	1.5614967025662256	3.9650816549857404	IFNB1;STAT1;STAT2;MX2;MX1;EIF2AK2;ISG15;OASL;CCNA2;WNT6;CCNE2;E2F1;ITGB8;IRF9
Primary bile acid biosynthesis	2/17	0.07945063861239245	0.376967923629011	0	0	4.684749849306812	11.864688109438605	CH25H;CYP7B1
Arachidonic acid metabolism	4/61	0.08904915496439575	0.40912295782080976	0	0	2.469258445569459	5.972066395198247	CYP2J2;JMJD7-PLA2G4B;ALOX5;LTC4S
TNF signaling pathway	6/112	0.09173160489255824	0.40912295782080976	0	0	1.9939168986493454	4.763244757898365	CXCL10;IL6;VCAM1;IFNB1;CCL2;NOD2
Toxoplasmosis	6/112	0.09173160489255824	0.40912295782080976	0	0	1.9939168986493454	4.763244757898365	STAT1;ALOX5;IL10RA;JAK2;TLR4;MYD88
Graft-versus-host disease	3/42	0.11040533967584856	0.47346905284065827	0	0	2.7042920847268674	5.9591693292174455	CD86;IL6;CD80
Tryptophan metabolism	3/42	0.11040533967584856	0.47346905284065827	0	0	2.7042920847268674	5.9591693292174455	KMO;IDO2;IDO1
Chagas disease	5/102	0.15399721261138044	0.6479505360818459	0	0	1.8133083411433928	3.3923749190990637	IL6;IFNB1;CCL2;TLR4;MYD88
FoxO signaling pathway	6/131	0.15742241034412024	0.6500173753790298	0	0	1.6891803278688524	3.122994723132078	PLK4;CCNB1;IL6;PLK1;TNFSF10;IL7R
Pancreatic cancer	4/76	0.1603181867526755	0.6500173753790298	0	0	1.9533172010485984	3.5757322549787967	RAD51;STAT1;E2F1;BRCA2
Linoleic acid metabolism	2/29	0.19183129230169063	0.7638996104156609	0	0	2.6010314111579933	4.294664348966432	CYP2J2;JMJD7-PLA2G4B
Pathways in cancer	18/531	0.22394770450891718	0.8761462825524304	0	0	1.2370217909765102	1.851008546952516	IL15RA;STAT1;STAT2;CALML4;BRCA2;KIF7;ADCY7;CCNA2;DLL4;WNT6;IL6;RAD51;CCNE2;STAT4;E2F1;BIRC5;JAK2;IL7R
Base excision repair	2/33	0.23278641777795375	0.8950236407669601	0	0	2.2649477921017325	3.301464700949223	NEIL3;POLE2
Hypertrophic cardiomyopathy	4/90	0.24009212160854648	0.9074668325204385	0	0	1.6341535474612754	2.331500122005218	MYBPC3;IL6;ITGB8;SLC8A1
Phagosome	6/152	0.2474604980256228	0.9197281843285648	0	0	1.4446440601841455	2.0174516617336016	FCGR3A;CLEC7A;CYBB;CD14;TLR4;FCGR2C
Th1 and Th2 cell differentiation	4/92	0.25218659813841393	0.9219280554896115	0	0	1.5968487048341857	2.199796414594974	DLL4;STAT1;STAT4;JAK2
Human T-cell leukemia virus 1 infection	8/219	0.26414947116235554	0.9500860011162142	0	0	1.3331831532616512	1.7747869508033232	CDC20;CCNA2;IL15RA;IL6;CCNE2;E2F1;BUB1B;ADCY7
Dilated cardiomyopathy	4/96	0.27673003375288635	0.9795364686808516	0	0	1.5271048686183224	1.9618912562940622	MYBPC3;ITGB8;ADCY7;SLC8A1
Allograft rejection	2/38	0.28455028337444194	0.9914798936328211	0	0	1.949869399236488	2.4506841862707933	CD86;CD80
Inflammatory mediator regulation of TRP channels	4/98	0.28914630645944295	0.9919942513916273	0	0	1.494458817623663	1.8543580787767704	CYP2J2;JMJD7-PLA2G4B;CALML4;ADCY7
Hematopoietic cell lineage	4/99	0.2953835888257007	0.9980384895171402	0	0	1.4786512560894067	1.8031863231195755	IL6;CD38;CD14;IL7R
Amoebiasis	4/102	0.3141887302027493	0.9996464806701492	0	0	1.433164191266343	1.6592622120857743	IL6;SERPINB9;CD14;TLR4
Bladder cancer	2/41	0.3154983193509224	0.9996464806701492	0	0	1.7996012426392174	2.0760234558577046	E2F1;TYMP
Yersinia infection	5/137	0.3317818670338899	0.9996464806701492	0	0	1.3300964187327824	1.4674655221253219	IL6;IFNB1;CCL2;TLR4;MYD88
Type I diabetes mellitus	2/43	0.33596666073530373	0.9996464806701492	0	0	1.7116393948749613	1.8669592840388123	CD86;CD80
Th17 cell differentiation	4/107	0.34572942330369755	0.9996464806701492	0	0	1.3632407097422163	1.4478963538686245	IL6;STAT1;IL21R;JAK2
Breast cancer	5/147	0.38688414790116676	0.9996464806701492	0	0	1.235787451984635	1.1735408259147864	DLL4;WNT6;E2F1;BRCA1;BRCA2
Glutamatergic synapse	4/114	0.38993518022691825	0.9996464806701492	0	0	1.2760270582412143	1.2017300742551469	GRK3;GRIN3A;JMJD7-PLA2G4B;ADCY7
B cell receptor signaling pathway	3/81	0.39110097449584585	0.9996464806701492	0	0	1.3494286510590858	1.266829456095057	IFITM1;DAPP1;LILRB2
Cholesterol metabolism	2/50	0.40588520400646483	0.9996464806701492	0	0	1.4614978902953586	1.3178105909196571	CETP;APOA2
Herpes simplex virus 1 infection	15/498	0.40987105010743535	0.9996464806701492	0	0	1.0905221992178513	0.9726505780521155	STAT1;IFNB1;DDX58;STAT2;CARD9;EIF2AK2;IFIH1;IL6;OAS1;OAS2;OAS3;CCL2;JAK2;MYD88;IRF9
Complement and coagulation cascades	3/85	0.4209863022637707	0.9996464806701492	0	0	1.2833377518557794	1.1102860496319087	C4A;CFH;CFB
One carbon pool by folate	1/20	0.4305682662728285	0.9996464806701492	0	0	1.845525365760973	1.5551308297796114	TYMS
Human cytomegalovirus infection	7/225	0.4335235151983094	0.9996464806701492	0	0	1.126607178731668	0.9416286889937511	IL6;IFNB1;IL10RA;E2F1;CCL2;CALML4;ADCY7
Autoimmune thyroid disease	2/53	0.43477345790370714	0.9996464806701492	0	0	1.3753146828351595	1.145541092547218	CD86;CD80
Endocrine and other factor-regulated calcium reabsorption	2/53	0.43477345790370714	0.9996464806701492	0	0	1.3753146828351595	1.145541092547218	CALB1;SLC8A1
Hedgehog signaling pathway	2/56	0.46288749138974566	0.9996464806701492	0	0	1.2987073873149821	1.0003569672648724	GRK3;KIF7
Morphine addiction	3/91	0.46482399431617	0.9996464806701492	0	0	1.1954668972332017	0.9158429483265166	GRK3;PDE4B;ADCY7
Mismatch repair	1/23	0.47671713977536967	0.9996464806701492	0	0	1.5936166721365277	1.1806021664706816	EXO1
GnRH signaling pathway	3/93	0.47911521757303716	0.9996464806701492	0	0	1.168780193236715	0.8600050310306102	JMJD7-PLA2G4B;CALML4;ADCY7
Salivary secretion	3/93	0.47911521757303716	0.9996464806701492	0	0	1.168780193236715	0.8600050310306102	CD38;CALML4;ADCY7
Notch signaling pathway	2/59	0.4901631982535875	0.9996464806701492	0	0	1.2301640176390343	0.8771277167184003	DLL4;DTX3L
Vitamin digestion and absorption	1/24	0.4912549255408459	0.9996464806701492	0	0	1.5242505101239994	1.0834252047117139	SLC46A1
MicroRNAs in cancer	9/310	0.49272206981106353	0.9996464806701492	0	0	1.048373553356942	0.7420493024421475	MIR221;CCNE2;CDCA5;STMN1;E2F1;KIF23;BRCA1;CDC25C;CDC25A
Viral carcinogenesis	6/203	0.4958065136666406	0.9996464806701492	0	0	1.0678205875010403	0.7491503789172412	CDC20;CCNA2;CCNE2;CDK1;EIF2AK2;IRF9
Chemical carcinogenesis	7/239	0.496146662576721	0.9996464806701492	0	0	1.0578514346841177	0.7414308331837371	PAQR8;DLL4;E2F1;BIRC5;JAK2;ADCY7;CDC25A
Mineral absorption	2/60	0.49905998665551077	0.9996464806701492	0	0	1.2088919373947746	0.8402149262091785	SLC46A1;SLC8A1
Viral myocarditis	2/60	0.49905998665551077	0.9996464806701492	0	0	1.2088919373947746	0.8402149262091785	CD86;CD80
alpha-Linolenic acid metabolism	1/25	0.5053895305255569	0.9996464806701492	0	0	1.460664861612515	0.9967953859393754	JMJD7-PLA2G4B
Vascular smooth muscle contraction	4/133	0.5064151802699187	0.9996464806701492	0	0	1.087015855597293	0.7396038834522343	PTGIR;JMJD7-PLA2G4B;CALML4;ADCY7
Systemic lupus erythematosus	4/135	0.5181399958454076	0.9996464806701492	0	0	1.0703093611892327	0.7037389057732512	CD86;C4A;FCGR3A;CD80
Basal cell carcinoma	2/63	0.5251445414087447	0.9996464806701492	0	0	1.1492603681854563	0.7402176145672892	WNT6;KIF7
Melanogenesis	3/101	0.5343668380164921	0.9996464806701492	0	0	1.0729259094942325	0.6723733908672838	WNT6;CALML4;ADCY7
Phototransduction	1/28	0.545484346006379	0.9996464806701492	0	0	1.2981682043053884	0.7867953050538898	CALML4
Acute myeloid leukemia	2/67	0.558471130052103	0.9996464806701492	0	0	1.0783140909723188	0.6281744117754452	CCNA2;CD14
Signaling pathways regulating pluripotency of stem cells	4/143	0.5636610583668308	0.9996464806701492	0	0	1.00829100784708	0.5780554212532016	WNT6;ID1;HESX1;JAK2
Fc epsilon RI signaling pathway	2/68	0.5665383194243974	0.9996464806701492	0	0	1.0619212011617074	0.6033948386817268	JMJD7-PLA2G4B;ALOX5
Amphetamine addiction	2/69	0.5744987550974793	0.9996464806701492	0	0	1.0460176513454427	0.5797629700526301	GRIN3A;CALML4
Drug metabolism	3/108	0.5798818322795467	0.9996464806701492	0	0	1.0010351966873705	0.5454950443453811	RRM2;TK1;TYMP
Prolactin signaling pathway	2/70	0.5823521397692459	0.9996464806701492	0	0	1.0305818529943622	0.5572149582180562	STAT1;JAK2
HIF-1 signaling pathway	3/109	0.5861509336260264	0.9996464806701492	0	0	0.9915401968826907	0.5296589163119029	IL6;CYBB;TLR4
Serotonergic synapse	3/113	0.6106222950962995	0.9996464806701492	0	0	0.9552865612648221	0.4712205890490237	CYP2J2;JMJD7-PLA2G4B;ALOX5
Leukocyte transendothelial migration	3/114	0.6165868072930627	0.9996464806701492	0	0	0.9466314140227183	0.4577494511696975	VCAM1;CLDN7;CYBB
Glioma	2/75	0.6200095002442018	0.9996464806701492	0	0	0.9597463400133766	0.4587784042943644	E2F1;CALML4
Thyroid hormone synthesis	2/75	0.6200095002442018	0.9996464806701492	0	0	0.9597463400133766	0.4587784042943644	TTF2;ADCY7
Oxytocin signaling pathway	4/154	0.6221962455207142	0.9996464806701492	0	0	0.9338173018753781	0.44309605642967204	JMJD7-PLA2G4B;CD38;CALML4;ADCY7
Nicotinate and nicotinamide metabolism	1/35	0.6268700906546614	0.9996464806701492	0	0	1.0305266510936504	0.48127238476915735	CD38
Gastric acid secretion	2/76	0.6272194975267169	0.9996464806701492	0	0	0.9467279214114657	0.44160949801808447	CALML4;ADCY7
Cushing syndrome	4/155	0.6272657220304417	0.9996464806701492	0	0	0.9275850049879208	0.4326117594837904	WNT6;CCNE2;E2F1;ADCY7
Arrhythmogenic right ventricular cardiomyopathy	2/77	0.634322842862232	0.9996464806701492	0	0	0.9340566606389391	0.4251800123201532	ITGB8;SLC8A1
DNA replication	1/36	0.6372425615019203	0.9996464806701492	0	0	1.001031459515214	0.45106968932447605	POLE2
Mucin type O-glycan biosynthesis	1/36	0.6372425615019203	0.9996464806701492	0	0	1.001031459515214	0.45106968932447605	GALNT12
Pathogenic Escherichia coli infection	5/197	0.641659302181232	0.9996464806701492	0	0	0.9116003787878788	0.40447508082841904	IL6;CLDN7;TNFSF10;TLR4;MYD88
Growth hormone synthesis, secretion and action	3/119	0.6454743429261955	0.9996464806701492	0	0	0.9055940779610195	0.3964417538598142	STAT1;JAK2;ADCY7
RNA degradation	2/79	0.6482110638212972	0.9996464806701492	0	0	0.9097015100631737	0.39439101009520167	PNPT1;PABPC4L
Primary immunodeficiency	1/38	0.6571319689458951	0.9996464806701492	0	0	0.9468240803980876	0.3975434192779766	IL7R
Platelet activation	3/124	0.672788599917258	0.9996464806701492	0	0	0.8679482572763205	0.3439888246739914	PTGIR;JMJD7-PLA2G4B;ADCY7
Nicotine addiction	1/40	0.6759327237362514	0.9996464806701492	0	0	0.8981764324724614	0.3517813344819822	GRIN3A
cGMP-PKG signaling pathway	4/167	0.6846472660425498	0.9996464806701492	0	0	0.8587620945742821	0.325343319206606	ADORA3;CALML4;ADCY7;SLC8A1
Ferroptosis	1/41	0.684943574612559	0.9996464806701492	0	0	0.8756768953068592	0.3313726147446952	CYBB
Salmonella infection	6/249	0.6926997388132381	0.9996464806701492	0	0	0.8636128538982212	0.3170829304319519	IL6;CASP5;TNFSF10;CD14;TLR4;MYD88
Purine metabolism	3/129	0.6985254307435762	0.9996464806701492	0	0	0.8332902001380262	0.2989709355943754	RRM2;PDE4B;ADCY7
ECM-receptor interaction	2/88	0.7055624390141478	0.9996464806701492	0	0	0.8141217040245595	0.2839330923311057	ITGB8;HMMR
Gap junction	2/88	0.7055624390141478	0.9996464806701492	0	0	0.8141217040245595	0.2839330923311057	CDK1;ADCY7
Natural killer cell mediated cytotoxicity	3/131	0.7083809415704185	0.9996464806701492	0	0	0.8201851222826086	0.28277791229163923	FCGR3A;IFNB1;TNFSF10
Vasopressin-regulated water reabsorption	1/44	0.7105029744066678	0.9996464806701492	0	0	0.8144572244144068	0.2783669372498745	AVPR2
Bile secretion	2/90	0.7171975948700345	0.9996464806701492	0	0	0.7955367417392734	0.26443950819384776	AQP9;ADCY7
Glycosphingolipid biosynthesis	1/45	0.7185541903761582	0.9996464806701492	0	0	0.7959058089924516	0.26305813573374753	FUT7
cAMP signaling pathway	5/216	0.7193461454549593	0.9996464806701492	0	0	0.8286945282205945	0.27298242816779733	GRIN3A;PDE4B;FFAR2;CALML4;ADCY7
Small cell lung cancer	2/92	0.7284439510559206	0.9996464806701492	0	0	0.7777777777777778	0.24643468404555097	CCNE2;E2F1
Neuroactive ligand-receptor interaction	8/341	0.7332958795500559	0.9996464806701492	0	0	0.8393914938704701	0.2603842802229148	PTGIR;P2RY6;GRIN3A;ADORA3;AVPR2;FPR3;FPR2;RXFP1
Nucleotide excision repair	1/47	0.7339922509872188	0.9996464806701492	0	0	0.7612227279861874	0.23541331077636465	POLE2
Other types of O-glycan biosynthesis	1/47	0.7339922509872188	0.9996464806701492	0	0	0.7612227279861874	0.23541331077636465	GALNT12
Apelin signaling pathway	3/137	0.7364618707661768	0.9996464806701492	0	0	0.7832170668397145	0.23958438963111572	CALML4;ADCY7;SLC8A1
Fluid shear stress and atherosclerosis	3/139	0.7453342051989967	0.9996464806701492	0	0	0.7716192455242967	0.226796306775196	VCAM1;CCL2;CALML4
Cocaine addiction	1/49	0.7485849286442612	0.9996464806701492	0	0	0.7294299037304453	0.21122146687047158	GRIN3A
Ether lipid metabolism	1/49	0.7485849286442612	0.9996464806701492	0	0	0.7294299037304453	0.21122146687047158	JMJD7-PLA2G4B
Ubiquitin mediated proteolysis	3/140	0.7496803131477496	0.9996464806701492	0	0	0.7659473183116471	0.22067586590530833	CDC20;UBE2C;BRCA1
Circadian entrainment	2/97	0.7549096492259879	0.9996464806701492	0	0	0.736651755972209	0.2071149500886584	CALML4;ADCY7
Fc gamma R-mediated phagocytosis	2/97	0.7549096492259879	0.9996464806701492	0	0	0.736651755972209	0.2071149500886584	FCGR3A;JMJD7-PLA2G4B
Prostate cancer	2/97	0.7549096492259879	0.9996464806701492	0	0	0.736651755972209	0.2071149500886584	CCNE2;E2F1
Apoptosis	3/142	0.7581942189297507	0.9996464806701492	0	0	0.7548482952768221	0.2089538597482468	TNFSF10;BIRC5;LMNB1
Aldosterone synthesis and secretion	2/98	0.759928018288245	0.9996464806701492	0	0	0.7289406268836649	0.2001172096077328	CALML4;ADCY7
Glycerophospholipid metabolism	2/98	0.759928018288245	0.9996464806701492	0	0	0.7289406268836649	0.2001172096077328	JMJD7-PLA2G4B;LPIN3
PI3K-Akt signaling pathway	8/354	0.7696060533433947	0.9996464806701492	0	0	0.8073041603702803	0.2114139993286357	IL6;CCNE2;IFNB1;ITGB8;BRCA1;JAK2;IL7R;TLR4
Pancreatic secretion	2/102	0.7791208319174548	0.9996464806701492	0	0	0.6996383363471971	0.1746221261772409	CD38;ADCY7
Phospholipase D signaling pathway	3/148	0.7823380750432868	0.9996464806701492	0	0	0.7233883058470765	0.1775689055129278	JMJD7-PLA2G4B;AVPR2;ADCY7
Transcriptional misregulation in cancer	4/192	0.7833985529514943	0.9996464806701492	0	0	0.7435996447464958	0.18152286423460445	CD86;CCNA2;IL6;CD14
Gastric cancer	3/149	0.7861626699223321	0.9996464806701492	0	0	0.7183963668850506	0.17284009454486793	WNT6;CCNE2;E2F1
Regulation of lipolysis in adipocytes	1/55	0.7877403293441732	0.9996464806701492	0	0	0.6481815750768819	0.15464755143100536	ADCY7
Adrenergic signaling in cardiomyocytes	3/150	0.7899315018021091	0.9996464806701492	0	0	0.7134723454599231	0.16824323160339283	CALML4;ADCY7;SLC8A1
Parathyroid hormone synthesis, secretion and action	2/106	0.796956897839717	0.9996464806701492	0	0	0.6725900681596884	0.1526474651408426	PDE4B;ADCY7
Calcium signaling pathway	5/240	0.7992673420019389	0.9996464806701492	0	0	0.7431334622823984	0.16650633005246268	CD38;CALML4;ADCY7;MCOLN2;SLC8A1
Glutathione metabolism	1/57	0.7993890726980472	0.9996464806701492	0	0	0.6249677668901495	0.1399349716260212	RRM2
VEGF signaling pathway	1/59	0.8103996191398383	0.9996464806701492	0	0	0.6033549109921573	0.126841973151756	JMJD7-PLA2G4B
Long-term depression	1/60	0.8156765520434497	0.9996464806701492	0	0	0.5930979624303984	0.12083622785387416	JMJD7-PLA2G4B
Shigellosis	5/246	0.8161761739114897	0.9996464806701492	0	0	0.7244058845718597	0.14714498001691112	RNF31;IFNB1;CD14;TLR4;MYD88
Glycerolipid metabolism	1/61	0.8208068736597679	0.9996464806701492	0	0	0.5831829121540313	0.11515963103394326	LPIN3
Steroid hormone biosynthesis	1/61	0.8208068736597679	0.9996464806701492	0	0	0.5831829121540313	0.11515963103394326	CYP7B1
Cholinergic synapse	2/113	0.8251183714905725	0.9996464806701492	0	0	0.6299464020983009	0.12109360303737794	JAK2;ADCY7
Hippo signaling pathway	3/163	0.8340750376986106	0.9996464806701492	0	0	0.6550611413043478	0.11884899233768512	WNT6;ID1;BIRC5
Cortisol synthesis and secretion	1/65	0.8399417020114862	0.9996464806701492	0	0	0.5466211642599278	0.09534318959305729	ADCY7
Long-term potentiation	1/67	0.8487299665909459	0.9996464806701492	0	0	0.5300021879444262	0.08692788687604737	CALML4
Mitophagy	1/68	0.8529417720901196	0.9996464806701492	0	0	0.5220647664206045	0.08304170808335944	E2F1
Adipocytokine signaling pathway	1/69	0.8570365121873108	0.9996464806701492	0	0	0.5143607984710129	0.07935288700889696	JAK2
Renin secretion	1/69	0.8570365121873108	0.9996464806701492	0	0	0.5143607984710129	0.07935288700889696	CALML4
Central carbon metabolism in cancer	1/70	0.8610174349583574	0.9996464806701492	0	0	0.5068801339402501	0.07584980940464132	SCO2
Melanoma	1/72	0.8686503735269429	0.9996464806701492	0	0	0.49255097371230994	0.06935835190833185	E2F1
Non-small cell lung cancer	1/72	0.8686503735269429	0.9996464806701492	0	0	0.49255097371230994	0.06935835190833185	E2F1
Lysosome	2/128	0.8739540814496152	0.9996464806701492	0	0	0.5545222308332616	0.07470936229892343	AP1G2;LAMP3
PPAR signaling pathway	1/74	0.875864817359989	0.9996464806701492	0	0	0.4790069729489145	0.06348926935852495	APOA2
Relaxin signaling pathway	2/129	0.8767167301321894	0.9996464806701492	0	0	0.5501274366020703	0.07238100262604094	RXFP1;ADCY7
Chronic myeloid leukemia	1/76	0.8826836723008405	0.9996464806701492	0	0	0.4661853188929001	0.05817451285819597	E2F1
Axon guidance	3/182	0.8841362556641081	0.9996464806701492	0	0	0.5849526354141366	0.07203346165150236	SEMA3D;SEMA3A;UNC5C
Estrogen signaling pathway	2/137	0.896885448439597	0.9996464806701492	0	0	0.5173129730091756	0.05629768630604169	CALML4;ADCY7
Colorectal cancer	1/86	0.9115619263904606	0.9996464806701492	0	0	0.41112762794648544	0.03806867030716856	BIRC5
Insulin secretion	1/86	0.9115619263904606	0.9996464806701492	0	0	0.41112762794648544	0.03806867030716856	ADCY7
Cardiac muscle contraction	1/87	0.9140266273550245	0.9996464806701492	0	0	0.4063260851313911	0.036526917133031696	SLC8A1
GABAergic synapse	1/89	0.9187522212928813	0.9996464806701492	0	0	0.39705037742041355	0.03364557678022642	ADCY7
TGF-beta signaling pathway	1/94	0.9294625810934761	0.9996464806701492	0	0	0.3756065370133147	0.02747514103372549	ID1
mTOR signaling pathway	2/154	0.9299668414642916	0.9996464806701492	0	0	0.4590511087846198	0.03333002446695372	WNT6;LPIN3
Rap1 signaling pathway	3/210	0.9335202748386544	0.9996464806701492	0	0	0.5050934677588742	0.03474669141185363	ID1;CALML4;ADCY7
Phosphatidylinositol signaling system	1/97	0.9351996971948913	0.9996464806701492	0	0	0.36381242478941034	0.024373683472969806	CALML4
Choline metabolism in cancer	1/98	0.9370066120629971	0.9996464806701492	0	0	0.3600431724291935	0.0234261874611577	JMJD7-PLA2G4B
mRNA surveillance pathway	1/98	0.9370066120629971	0.9996464806701492	0	0	0.3600431724291935	0.0234261874611577	PABPC4L
Regulation of actin cytoskeleton	3/218	0.9435586909313874	0.9996464806701492	0	0	0.4860970677451972	0.02824064065058601	DIAPH3;ITGB8;IQGAP3
Longevity regulating pathway	1/102	0.9437450726571617	0.9996464806701492	0	0	0.34571254959430964	0.020016479864114096	ADCY7
Protein digestion and absorption	1/103	0.9453140903997527	0.9996464806701492	0	0	0.3423055142634671	0.01925058980605826	SLC8A1
Wnt signaling pathway	2/166	0.9469801165458822	0.9996464806701492	0	0	0.4251973713227187	0.023163554699187416	VANGL1;WNT6
Hepatocellular carcinoma	2/168	0.9494023428604648	0.9996464806701492	0	0	0.4200309374931916	0.021809100514248496	WNT6;E2F1
Tight junction	2/169	0.9505735453948718	0.9996464806701492	0	0	0.4174941256727052	0.021162670588067495	CLDN7;AMOTL2
Glucagon signaling pathway	1/107	0.9511652661055701	0.9996464806701492	0	0	0.3293202097949731	0.016488223184371126	CALML4
Insulin resistance	1/108	0.9525276589118723	0.9996464806701492	0	0	0.32622558115995814	0.015866351136676605	IL6
Ribosome biogenesis in eukaryotes	1/108	0.9525276589118723	0.9996464806701492	0	0	0.32622558115995814	0.015866351136676605	PWP2
Protein processing in endoplasmic reticulum	2/171	0.9528388330529204	0.9996464806701492	0	0	0.4125105663567202	0.019928181267548202	EIF2AK2;SEC31B
Ras signaling pathway	3/232	0.9578164846994086	0.9996464806701492	0	0	0.4560470856274919	0.019655209926629835	JMJD7-PLA2G4B;CALML4;RGL1
MAPK signaling pathway	4/294	0.9647362748978341	0.9996464806701492	0	0	0.4795043494586645	0.017214448417560885	JMJD7-PLA2G4B;STMN1;CD14;MYD88
Neurotrophin signaling pathway	1/119	0.9652279190815203	0.9996464806701492	0	0	0.2956464541393869	0.010463229557737512	CALML4
Sphingolipid signaling pathway	1/119	0.9652279190815203	0.9996464806701492	0	0	0.2956464541393869	0.010463229557737512	ADORA3
AMPK signaling pathway	1/120	0.9661985567526146	0.9996464806701492	0	0	0.29314686163273973	0.01008012470783123	CCNA2
Alcoholism	2/186	0.966929334902615	0.9996464806701492	0	0	0.37858715307807217	0.012731834025365965	GRIN3A;CALML4
RNA transport	2/186	0.966929334902615	0.9996464806701492	0	0	0.37858715307807217	0.012731834025365965	PABPC4L;TACC3
Thyroid hormone signaling pathway	1/121	0.9671421452645261	0.9996464806701492	0	0	0.29068892900120336	0.009711858455354234	STAT1
Dopaminergic synapse	1/132	0.9759373547813809	0.9996464806701492	0	0	0.26612836553035524	0.0064820567446815195	CALML4
Alzheimer disease	5/369	0.9772770960565049	0.9996464806701492	0	0	0.47654845154845155	0.010953488962299545	WNT6;IL6;EIF2AK2;CYBB;CALML4
Proteoglycans in cancer	2/205	0.9790512801149854	0.9996464806701492	0	0	0.3428143845927721	0.007257811688528434	WNT6;TLR4
Insulin signaling pathway	1/137	0.979115619718691	0.9996464806701492	0	0	0.2562778721596942	0.0054088838071595395	CALML4
Spinocerebellar ataxia	1/143	0.9823812043105279	0.9996464806701492	0	0	0.2453729597803427	0.004361713955801071	GRIN3A
Prion disease	3/273	0.9825498149606261	0.9996464806701492	0	0	0.38597020933977455	0.006794709988015825	IL6;GRIN3A;CYBB
Retrograde endocannabinoid signaling	1/148	0.9847094684533769	0.9996464806701492	0	0	0.23696554434047987	0.003651316102350837	ADCY7
Non-alcoholic fatty liver disease	1/155	0.9874621302542747	0.9996464806701492	0	0	0.22611233531811148	0.0028528891932497902	IL6
Focal adhesion	1/201	0.9966025346734391	0.9996464806701492	0	0	0.1736913357400722	5.911150066305158E-4	ITGB8
Diabetic cardiomyopathy	1/203	0.9967901878872149	0.9996464806701492	0	0	0.17195374772134253	5.52826932974042E-4	CYBB
Thermogenesis	1/232	0.9985920130122254	0.9996464806701492	0	0	0.15013987216153282	2.1154394688401831E-4	ADCY7
Parkinson disease	1/249	0.9991313615796311	0.9996464806701492	0	0	0.13972429253522767	1.214226325749351E-4	CALML4
Endocytosis	1/252	0.9992023038685311	0.9996464806701492	0	0	0.13803270671825335	1.1015209595905616E-4	GRK3
Pathways of neurodegeneration	4/475	0.999261261975774	0.9996464806701492	0	0	0.2924464686865417	2.161211647628354E-4	WNT6;IL6;CYBB;CALML4
Olfactory transduction	3/440	0.9996464806701492	0.9996464806701492	0	0	0.23639438861804796	8.358476112978172E-5	GRK3;CALML4;SLC8A1
